CADE approves pharma merger with restrictions
Brazil’s antitrust tribunal, CADE, has approved French pharmaceutical company Sanofi-Aventis’ purchase of Brazilian generics group Medley, on the condition that they divest three drugs.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.
Subscribe now